Skip Navigation
Skip to contents

KDDW 2018

d-Day
D0

  • Advancing Gastroenterology and Hepatology through Creative Integration
  • Abstract Submission and Registration are available via APDW 2018 website (www.apdw2018.org)

Program Details

Home    >    Scientific Program    >    Program Details
Symposium EN-01 (UG)
Nov. 16 (Fri)
08:30-10:00
Minimal invasive therapy of early gastric cancer: from ESD to surgery 101 (1F)
Chairperson(s) Hyung-Ho Kim (Seongnam), Takuji Gotoda (Tokyo)
08:30-08:50 How to choose a patient with early gastric cancer who can be treated with endoscopic submucosal dissection Ning Bo/ Enqiang Linghu
(Beijing)
08:50-09:10 ESD for early gastric cancer with undifferentiated histology: do we have enough data? Takuji Gotoda
(Tokyo)
09:10-09:30 Risk stratification of noncurative ESD: do all patient need additional treatment? Jun Chul Park
(Seoul)
09:30-09:50 Sentinel node navigation surgery for early gastric cancer: when and how to perform? Masanori Terashima
(Nagaizumi)
09:50-10:00 Q&As
Symposium EN-02 (LG)
Nov. 16 (Fri)
08:30-10:00
Progress in the detection and management of colorectal neoplasm 102 (1F)
Chairperson(s) Hermann Brenner (Heidelberg), Han-Mo Chiu (Taipei)
08:30-08:50 Image enhanced endoscopy in colorectal cancer screening: current status Wai Keung Leung
(Hong Kong)
08:50-09:10 Computer-aided detection and histopathology prediction for colorectal polyps Jeong-Sik Byeon
(Seoul)
09:10-09:30 Detection and removal of serrated lesions Hyo-Joon Yang
(Seoul)
09:30-09:50 Recent advances in colorectal ESD Takahisa Matsuda
(Tokyo)
09:50-10:00 Q&As
Symposium LV-01
Nov. 16 (Fri)
08:30-10:00
Chronic hepatitis B: current medication 103 (1F)
Chairperson(s) Seung Kew Yoon (Seoul), George Lau (Hong Kong)
08:30-08:50 Can we stop the neucleot(s)ide analogue? George Lau
(Hong Kong)
08:50-09:10 Prevention of new HBV infection: nucleotide analogue in pregnant women and vaccination Henry LY Chan
(Hong Kong)
09:10-09:30 HBV and HCV coinfection Jidong Jia
(Beijing)
09:30-09:50 Bepatitis B prophylaxis and occult hepatitis B in immunocompromized patients: to whom and how long Seng Gee Lim
(Singapore)
09:50-10:00 Q&As
Symposium PB-01
Nov. 16 (Fri)
08:30-10:00
New insights in the biliary system 104 (1F)
Chairperson(s) D. Nageshwar Reddy (Hyderabad), Ho Soon Choi (Seoul), Shutian Zhang (Beijing)
08:30-08:50 Optimal evaluation of premalignant biliary lesions Seon Mee Park
(Cheongju)
08:50-09:10 Optimal approach to the indeterminate bile duct stricture Hsiu-Po Wang
(Taipei)
09:10-09:30 Updates on difficult biliary stones management Chang-Il Kwon
(Seongnam)
09:30-09:50 Best Endoscopic drainage of biliary system Shutian Zhang
(Beijing)
09:50-10:00 Q&As
Symposium GI-01 (Motility)
Nov. 16 (Fri)
08:30-10:00
Updates in gastrointestinal neurogastro-motility disorders 105 (1F)
Chairperson(s) Nicholas J Talley (Newcastle), Kwang Jae Lee (Suwon)
08:30-08:50 Approach to esophageal disorders John Pandolfino
(Wilmette)
08:50-09:10 Approach to gastric disorders Nicholas J Talley
(Newcastle)
09:10-09:30 Approach to bowel disorders Eamonn Quigley
(Houston)
09:30-09:50 Differences of guidelines between Asia and West Jung-Ho Park
(Seoul)
09:50-10:00 Q&As
SIDDS 1
Nov. 16 (Fri)
08:30-10:00
Understanding of molecular alteration: the cornerstone for treatment of GI cancer 202 (2F)
Chairperson(s) James R. Goldenring (Nashville), Seung Woo Park (Seoul)
08:30-08:55 The mechanisms responsible for the development of pre-neoplastic lineages from metaplasias in the stomach and their roles in gastric carcinogenesis James R. Goldenring
(Nashville)
08:55-09:20 Proteomic Multi-Marker Panel for Early Detection of GI cancers Using Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS) Youngsoo Kim
(Seoul)
09:20-09:45 Control of GI cancer using CRIPR-Cas9 Hyongbum Kim
(Seoul)
09:40-10:00 Q&As
Symposium EN-03 (UG)
Nov. 16 (Fri)
08:30-10:00
Recent update in treatment for GI subepithelial tumors 203 (2F)
Chairperson(s) Hoon Jai Chun (Seoul), Seigo Kitano (Oita)
08:30-08:50 Resection for subepithelial tumors: when is it needed? Jie-Hyun Kim
(Seoul)
08:50-09:10 Endoscopic resection of subepithelial tumors via standard EMR/ESD technique Kyoung Oh Kim
(Inchoen)
09:10-09:30 Endoscopic full thickness resection of subepithelial tumors Chan Gyoo Kim
(Goyang)
09:30-09:50 Minimally invasive surgery for subepithelial tumors Osamu Goto
(Tokyo)
09:50-10:00 Q&As
E-poster Presentation-01 (UG, Motility)
Nov. 16 (Fri)
08:30-10:00
Esophagus R1A (3F)
Chairperson(s) Jung-Ho Park (Seoul), William Tam (Adelaide)
08:30-08:36 Utility of adjunctive rapid drink test (RDT) during high resolution esophageal manometry (HREM) in sitting position for evaluating functional esophagogastric junction outflow obstruction (EGJOO) Tanisa Patcharatrakul
(Bangkok)
08:36-08:42 Reduction of proton pump inhibitor (PPI) usage in patients with gastroesophageal reflux disease (GERD) after undergoing stretta procedure, an east malaysia perspective. Phei Oon Tan
(Kota Kinabalu)
08:42-08:48 The relationship between hypomotility disorders, hypotensive lower esophageal sphincter and gastroesophageal reflux diseases symptoms. Hang Dao
(Hanoi)
08:48-08:54 Taking the next steps in endoscopic visual assessment of barretts esophagus Roxana Chis
(Kingston)
08:54-09:00 Do we need to exclude epigastric symptoms for GERD diagnosis? Mengyu Zhang
(Guangzhou)
09:00-09:06 Effect of anti-reflux mucosectomy (ARMS) for refractory GERD underwent 24-hour pH-impedance (MII-pH) off PPI before and after ARMS Kazuya Sumi
(Tokyo)
09:06-09:12 Immunohistochemical expression of transient receptor vanilloid 4 (TRPV4), a marker of visceral hypersensitivity in NERD and controls Mung Seong Wong
(Kota Bharu)
09:12-09:18 Normative values for 24-hours ambulatory multichannel intraluminal impedance and pH monitoring (sandhill and MMS systems) in the malay population Su Fui Thung
(Kota Bharu)
09:18-09:24 Normative Chicago 3.0 metrics for high-resolution esophageal manometry (sandhill and MMS systems) in the malay population and the effects of boluses types and postures on normative Metrics Su Fui Thung
(Kota Bharu)
09:24-09:30 Effects of provocative bolus and positions on chicago 3.0 metrics in normal malay population. Su Fui Thung
(Kota Bharu)
09:30-09:36 Clinical characteristics of untreated achalasia patients in Taiwan: a prospective study based on high-resolution impedance manometry Ping-Huei Tseng
(Taipei)
09:36-09:42 Prevalence and risk factors of Barrett's esophagus in Vietnamese patients with upper gastrointestinal symptoms Quyen Thi Trieu Pham
(Ho Chi Minh)
09:42-09:48 The endoscopic and clinicopathological characteristics of Barrett's esophagus in Vietnamese patients Truc Le Thanh Tran
(Ho Chi Minh)
09:48-09:54 Pneumatic dilation, more than a treatment of achalasia - evaluation of compliance of esophagogastric junction by pneumatic dilation balloon before POEM Hailong Cao
(Tianjin)
E-poster Presentations-02 (LG)
Nov. 16 (Fri)
08:30-10:00
Inflammatory bowel disease (1) R1C (3F)
Chairperson(s) Tae Oh Kim (Busan), Chang Hwan Choi (Seoul)
08:30-08:36 Do patients, their families, and doctors really think the same? A population-based, multi-centered cohort study using the inflammatory bowel disease disability index Jun Shen
(Shanghai)
08:36-08:42 Using magnetic resonance imaging to evaluate the effectiveness in perianal fistulising Crohns disease Jun Shen
(Shanghai)
08:42-08:48 Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease Sang Hyoung Park
(Seoul)
08:48-08:54 Endoscopic diagnosis of non-pedunculated dysplasia during surveillance in the ulcerative colitis: a survey-based, multinational studies Dong-Hoon Yang
(Seoul)
08:54-09:00 Infliximab trough levels are associated with transmural healing during maintenance treatment in pediatric Crohn's disease patients Ben Kang
(Daegu)
09:00-09:06 Impact of superimposed cytomegalovirus infection on the outcomes of ulcerative colitis flare-up Shin Ju Oh
(Seoul)
09:06-09:12 Histone H3 acetylation protects ulcerative colitis by inhibiting NF-B/p65 and enhancing intestinal epithelial barrier function Chunxiao Li
(Hangzhou)
09:12-09:18 Helicobacter pylori infection in inflammatory bowel disease: protective or harmful? Yang Yu
(Beijing)
09:18-09:24 The Efficacy and safety of adalimumab for the patients with moderate to severely active ulcerative colitis and predictors of response in Korea (EUREKA): preliminary results Chang Hwan Choi
(Seoul)
09:24-09:30 Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring Sung-Shuo Kao
(Kaohsiung)
09:30-09:36 Doctors perspectives on the use of traditional, complementary and alternative medicine in inflammatory bowel disease: the first doctors report in Asia Jessica Y L Ching
(Hong Kong)
E-poster Presentations-03 (LV)
Nov. 16 (Fri)
08:30-10:00
Acute hepatitis, viral hepatitis, liver failure, HCC R2A (3F)
Chairperson(s) Jong Young Choi (Seoul), Young Oh Kwon (Daegu)
08:30-08:36 Hormonal component of the pathogenesis of chronic liver disease Saidrakhim Nodirovich Lukmonov
(Tashkent)
08:36-08:42 Inflammatory cytokines and the change of Th1/Th2 balance as prognostic indicators for HCC in patients treated with transarterial chemoembolization Hae Lim Lee
(Bucheon)
08:42-08:48 Clinical characteristics of long term survivors following sorafenib treatment for unresectable hepatocellular carcinoma: Korean national multi-center retrospective cohort study Young Youn Cho
(Seoul)
08:48-08:54 Assessing HCV distribution among hard to reach populations in London using whole genome sequencing: report from the TB reach study Dewi Nur Aisyah
(Depok)
08:54-09:00 Modelling hepatitis C direct acting antiviral (DAA) treatment scale up among people who inject drugs in London: working towards WHO incidence elimination target by 2030 Dewi Nur Aisyah
(Depok)
09:00-09:06 Evaluation of utility of predictive models for acute-on-chronic liver failure Li Peng Margaret Teng
(Singapore)
09:06-09:12 Early hepatitis is the strongest risk factor for the development of severe dengue infection: a points-based risk-score to predict critical disease in dengue fever Madunil Anuk Niriella
(Ragama)
09:12-09:18 Barriers to hepatocellular carcinoma (HCC) surveillance in at-risk individuals in Thailand Palada Pitakkitnukun
(Bangkok)
09:18-09:24 Temporal profile of HEV RNA concentration in blood and stool in patients with acute hepatitis E Vijay Kumar Halkurike Jayadevappa
(Lucknow)
09:24-09:30 miRNA-221-5p promotes epithelial-mesenchymal transition in hepatocellular carcinoma through regulation of CD44/TGF-beta1 Na Ri Park
(Seoul)
09:30-09:36 Understanding recurrence related oncogenic kinases and metabolites in liver cancer Hongping Xia
(Singapore)
E-poster Presentations-04 (LG)
Nov. 16 (Fri)
08:30-10:00
Irritable bowel disease (IBS), microbiology R2C (3F)
Chairperson(s) Byung Ik Jang (Daegu), Shengtao Zhu (Beijing)
08:30-08:36 Maternal western-style diet alters gut microbiota of offspring and exacerbates intestinal inflammation in adulthood Hailong Cao
(Tianjin)
08:36-08:42 Profiles of bacteria-derived extracellular vesicles in stool, serum and urine in patients with colorectal cancer: a preliminary study Jae Ho Cho
(Seongnam)
08:42-08:48 Characteristics of mucosa-associated fungal microbiota during treatment in Crohn's disease Cong He
(Nanchang)
08:48-08:54 The impact of helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: an open-label, prospective clinical trial Luyi Chen
(Hangzhou)
08:54-09:00 Bloating and its association with functional gastrointestinal disorders according to ROME III diagnostic criteria Kewin Tien Ho Siah
(Singapore)
09:00-09:06 Transcriptome and methylome profiling in a rat model of irritable bowel syndrome induced by stress Shengtao Zhu
(Beijing)
09:06-09:12 Investigating the functional role of clostridium hathewayi in colorectal carcinogenesis Thomas Kwong
(Hong Kong)
09:12-09:18 The impact of veterinary antibiotic residue in foods on obesity and antibiotic resistance through modulation of gut microbiota Wei-Kai Wu
(Taipei)
09:18-09:24 Overlapping functional GI disorders (FGID) and new-onset constipation associated with more GI symptom severity in FGID patients during hospitalization Tanisa Patcharatrakul
(Bangkok)
PG Course-LV (Korean)
Nov. 16 (Fri)
08:30-10:00
Concerning points and management during treatment for liver disease E1+2 (3F)
Chairperson(s) So Young Kwon (Seoul), June Sung Lee (Goyang)
08:30-08:50 During antiviral therapy for HBV Hyun Phil Shin
(Seoul)
08:50-09:10 During antiviral therapy for HCV In Hee Kim
(Jeonju)
09:10-09:30 During imunosuppressive therapy for Autoimmune liver disease Eun Ju Cho
(Seoul)
09:30-09:50 During systemic therapy for HCC Sung-Bum Cho
(Gwangju)
09:50-10:00 Q&As
Free Paper (PB 1) (Korean)
Nov. 16 (Fri)
08:30-10:00
KDDW Free Paper (PB 01) E3 (3F)
Chairperson(s) Young Woo Choi (Daejeon), Kyu Taek Lee (Seoul)
08:30-08:40 Comparison of therapeutic efficacy and safety between standard-dose FOLFIRINOX and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer: a retrospective study Huapyong Kang
(Seoul)
08:40-08:50 Korean experiences with liposomal irinotecan for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy. Juyeon Oh
(Goyang)
08:50-09:00 Comparison of FOLFIRINOX and Gemcitabine with Nab-paclitaxel in Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer Registry (K-PAC) Jong-Chan Lee
(Seongnam)
09:00-09:10 Surveillance versus surgery for incidental, asymptomatic, small solid pseudopapillary neoplasm (SPN) of the pancreas Joune Seup Lee
(Seoul)
09:10-09:20 Efficacy of endobiliary radiofrequency ablation for malignant distal biliary obstruction: A propensity score matched multicenter study Eui Joo Kim
(Incheon)
Chairperson(s) Seokho Dong (Seoul), Don Haeng Lee (Incheon)
09:20-09:30 The importance of elevated serum viscosity in pancreaticobiliary cancer patients Hwang Seonyeong
(Seoul)
09:30-09:40 Prognostic impact of minimal Pelvic Fluid in pancreatic cancer stage III Young-Hwa Kim
(Incheon)
09:40-09:50 Chromogranin A as a prognostic marker in pancreatic adenocarcinoma Jung Hyun Jo
(Seoul)
09:50-10:00 complementary role of Serum DUPAN-2 for screening of Carbohydrate Antigen 19-9 in patients with pancreatico-biliary malignancy Jae Woo Kim
(Wonju)
Free Paper (GI Cancer 1) (Korean)
Nov. 16 (Fri)
08:30-10:00
KDDW Free Paper (GI Cancer 01) E4 (3F)
Chairperson(s) Jin Tae Jung (Daegu), Su Youn Nam (Daegu)
08:30-08:40 Effects of a 12 week home-based exercise program in patients with high risk of gastric cancer: A pilot study Jeung Eun Lee
(Seoul)
08:40-08:50 Subepithelial spread of early gastric signet ring cell carcinoma: How far they can reach? Sun Hyung Kang
(Daejeon)
08:50-09:00 Gastric cancer with lymph node metastasis more than 15 (N3b): is it really stage III disease? Sa-Hong Kim
(Seoul)
09:00-09:10 Predictive factors of lymph node metastasis in early gastric cancer patients with Seiwert type II/III Min Young Son
(Busan)
09:10-09:20 Abdominal computed tomography compared with endoscopic ultrasound sonography for the diagnosis of gastric subepithelial tumors Cheal Wung Huh
(Incheon)
Chairperson(s) Eun Kwang Choi (Jeju), Seung-Ok Lee (Jeonju)
09:30-09:40 Incidence and prognosis of subsequent cholangiocarcinoma in patients with hepatic resection for bile duct stones Seon Mee Park
(Cheongju)
09:40-09:50 Validation of the 8th edition of the American Joint Commission on Cancer (AJCC) staging system for pancreatic adenocarcinoma: Using Korean pancreatic cancer (K-PAC) registry Dong Woo Shin
(Seongnam)
09:50-10:00 Clinicopathologic characteristics of Intraductal Papillary Neoplasm of Bile duct (IPNB) after central review: Korean multi-center collaboration study Jae Ri Kim
(Seoul)
10:00-10:10 Adjuvant gemcitabine-based chemotherapy vs concurrent chemoradiotherapy after R0 resection for pancreatic ductal adenocarcinoma: A propensity score-matched analysis Min Su You
(Seoul)
Free Paper (LG 1) (Korean)
Nov. 16 (Fri)
08:30-10:00
KDDW Free Paper (LG 01) E5 (3F)
Chairperson(s) Kyu Chan Huh (Daejeon), Sung-Ae Jung (Seoul)
08:30-08:40 A trial for the administration of a functionally enhanced tonsil-derived mesenchymal stem cells in a chronic colitis model. Yang Hee Joo
(Seoul)
08:40-08:50 The ability of epithelial regeneration is reduced in the Crohn's disease patient-derived organoids, especially in TNF-alpha enriched condition. Sung Noh Hong
(Seoul)
08:50-09:00 Diagnostic role of NOD signaling and apoptosis tests in patients with XIAP-deficient IBD Seak Hee Oh
(Seoul)
09:00-09:10 Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers Soo-Kyung Park
(Seoul)
09:10-09:20 Identification of prominent hub genes of colorectal cancer : Using network analysis of gene expression data Seong Ji Choi
(Seoul)
Chairperson(s) Byong Duk Ye (Seoul), Geom Seog Seo (Iksan)
09:20-09:30 Vegetarianism as a protective factor for asymptomatic colonic diverticulosis; A cross-sectional, case-control study between Buddhist priests and general population Jihun Bong
(Goyang)
09:30-09:40 Clinical outcome after endoscopic decompression of sigmoid volvulus; A multicenter-retrospective study, Daejeon-Chungchung intestinal research group Hee Seok Moon
(Daejeon)
09:40-09:50 Identification and validation of a peptide probe binding specifically to colon cancer cells Younghee Choe
(Seoul)
Mastering NBI
Nov. 16 (Fri)
08:50-11:40
Mastering NBI - Collaboration with ANBIIG 205 (2F)
Chairperson(s) Rajvinder Singh (Adelaide), Bo-In Lee (Seoul)
08:50 - 09:10 NBI in the Oesophagus: Current and best practice, 2018 Rajvinder Singh
(Adelaide)
09:10 - 09:25 Case discussion: esophagus Jung-Wook Kim
(Seoul)
09:25 - 09:45 NBI detection and characterization of stomach cancers Mitsuhiro Fujishiro
(Tokyo)
09:45 - 10:00 Case discussion: stomach Jun-Hyung Cho
(Seoul)
10:30 - 10:50 NBI detection and characterization of colorectal polyps Nozomu Kobayashi
(Tochigi)
10:50 - 11:05 Case discussion: colon, histologic prediction Han Hee Lee
(Seoul)
11:05 - 11:25 Estimation of invasion depth in colorectal lesions David Hewett
(Brisbane)
11:25 - 11:40 Case discussion: estimation of invasion depth Yunho Jung
(Cheonan)
Free Paper (LG 2) (Korean & English)
Nov. 16 (Fri)
10:20-11:10
KDDW Free Paper (LG 02) E5 (3F)
Chairperson(s) Jin-Oh Kim (Seoul), Chang Hwan Choi (Seoul)
10:20-10:30 Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin Kyung Mo Yoo
(Seoul)
10:30-10:40 Clinicopathological features of malignant tumors of small bowel diagnosed by video capsule endoscopy and balloon-assisted enteroscopy: A single center experience Sunghee Kam
(Seoul)
10:40-10:50 Modifiable lifestyle risk factors and the risk of colorectal neoplasia recurrence Kyungjin Ko
(Seoul)
10:50-11:00 Differences in the clinicopathologic characteristics between right- and left-sided colon cancer Hannah Ra
(Incheon)
11:00-11:10 Epidemiology of colorectal cancer in Northern Malaysia: A 7-year review (2008-2014) Mohamad Fadli Abd Rahman
(Alor Setar)
SIDDS 2
Nov. 16 (Fri)
10:30-12:00
Host-microbiome interactions in Gut and Liver disease 202 (2F)
Chairperson(s) Takanori Kanai (Tokyo), Jin-Wook Kim (Seongnam)
10:30-10:50 Understanding human gut microbiome and diseases Jongsik Chun
(Seoul)
10:50-11:10 The innate immune capacity of macrophages in regulation of intestinal barrier function and inflammation Eunok Im
(Busan)
11:10-11:30 T cells and immunoregulatory cytokines in intestinal inflammation: implication on IBD treatment Takanori Kanai
(Tokyo)
11:30-11:50 Gut-liver axis in Liver diseases Ki Tae Suk
(Chuncheon)
11:50-12:00 Q&As
Plenary 2 (UG, LG, Motility)
Nov. 16 (Fri)
10:30-12:00
KDDW Plenary 2 (UG, LG, Motility) 203 (2F)
Chairperson(s) Yong Chan Lee (Seoul), Tae Il Kim (Seoul), In Kyung Sung (Seoul)
10:30-10:45 Trough levels of infliximab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on infliximab maintenance therapy Eun Hye Oh
(Seoul)
10:45-11:00 Link between symptom severity, gender and self-reported psychiatric disorders in patients with organic and functional gastrointestinal disorders: A prospective cohort study in 12,806 consecutive patients referred for specialist treatment at a tertiary cen Ayesha Shah
(Brisbane)
11:00-11:15 utility of measurement EGJ distensibility in patients with achalasia Junsu Chang
(Sungnam)
11:15-11:30 Transient Receptor Vanilloid 4 (TRPV4), a Marker of Visceral Hypersensitivity is present in NERD and Controls Nazihah Azis
(Kota Bharu)
11:30-11:45 Metachronous recurrence of gastric epithelial neoplasia according to Helicobacter pylori infection and microsatellite state : Long term follow-up results and clinical outcome Jaeyoung Kim
(Suwon)
11:45-12:00 Association between family history of colorectal cancer and the risk of metachronous colorectal neoplasia following polypectomy in patients aged <50 years Hyun Beom Chae
(Seoul)
PG Course-Endoscopy (Korean)
Nov. 16 (Fri)
10:30-12:00
Basic drainage technique of Pancreatobiliary diseases (PG course) E1+2 (3F)
Chairperson(s) Sang-Heum Park (Cheonan), Dae Hwan Kang (Yangsan)
10:30-10:50 Biliary drainage: benign and malignant distal biliary obstruction Dong-Won Ahn
(Seoul)
10:50-11:10 Biliary drainage: advanced hilar obstruction Tae Hoon Lee
(Cheonan)
11:10-11:30 Obstructed pancreatic duct drainage: transpapillary and EUS-guided drainage Se Woo Park
(Hwaseong)
11:30-11:50 Gallbladder drainage: transpapillary and transmural drainage Woo Hyun Paik
(Seoul)
11:50-12:00 Q&As
Free Paper (PB 2) (Korean & English)
Nov. 16 (Fri)
10:30-12:00
KDDW Free Paper (PB 02) E3 (3F)
Chairperson(s) Tae Nyeun Kim (Daegu), Young Deok Cho (Seoul)
10:30-10:40 Differences in clinical features and outcomes of hypertriglyceridemia induced acute pancreatitis from the prospective acute pancreatitis registry of 558 patients. So Jeong Kim
(Incheon)
10:40-10:50 Acute pancreatitis in pregnant women. Features of diagnosis and treatment tactics Nurmurod Ne'mat O'g'li Esanov
(Tashkent)
10:50-11:00 Risk factors and outcomes of deep vein thrombosis in patients with necrotizing pancreatitis Du-Jiang Yang
(Chengdu)
Chairperson(s) Hong Sik Lee (Seoul), Byung Moo Yoo (Suwon)
11:00-11:10 Comparison between groove pancreatitis and groove pancreatitis with extensive chronic pancreatitis Jae Hyuck Jun
(Daejeon)
11:10-11:20 Comparison of clinical outcomes between plastic stent and lumen-apposing metal stent for endoscopic ultrasound-guided drainage of peripancreatic fluid collections: A retrospective single centre experience Chang Min Cho
(Daegu)
11:20-11:30 Efficacy of intramuscular diclofenac in the prevention of post-ERCP pancreatitis: A prospective, randomized, placebo-controlled study Byung Sam Park
(Daegu)
Free Paper (GI Cancer 2) (Korean & English)
Nov. 16 (Fri)
10:30-12:00
KDDW Free Paper (GI Cancer 02) E4 (3F)
Chairperson(s) Yun Jeong Lim (Goyang), Bora Keum (Seoul)
10:30-10:40 Changing trends of colonoscopic burden: A nationwide population-based study in Korea Jae Myung Cha
(Seoul)
10:40-10:50 Risk of developing colorectal cancer based on the prior screening behaviors: Population-based cohort study. Su Young Kim
(Wonju)
10:50-11:00 Colorectal cancer screening among cancer survivors in the US Adeyinka O Laiyemo
(Washington)
11:00-11:10 Metabolically healthy obesity is associated with an increased risk of colorectal neoplasia recurrence Hyun Beom Chae
(Seoul)
11:10-11:20 Association between low relative muscle mass and the risk of colorectal neoplasia recurrence in Korean men and women Kyung Mo Yoo
(Seoul)
Chairperson(s) Jin-Hyeok Hwang (Seongnam), Jae Hee Cho (Incheon)
11:20-11:30 Neoadjuvant FOLFIRINOX in patients with locally advanced pancreatic cancer Young Hoon Choi
(Seoul)
11:30-11:40 Lymphocyte-to-monocyte ratio is a valuable marker for predicting survival in patients with gallbladder cancer undergoing chemotherapy compared to neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio Young Hoon Choi
(Seoul)
11:40-11:50 Clinicopathologic characteristics and kras molecular alterations of adenosquamous carcinoma of the pancreas compared to pancreatic ductal adenocarcinoma Sun Mi Lee
(Jeju)
11:50-12:00 Detection of circulating tumor DNA and its application in pancreatic cancer patients Joo Kyung Park
(Seoul)
Okuda Lectureship
Nov. 16 (Fri)
11:00-11:30
Okuda Lectureship Auditorium (3F)
Chairperson(s) Rakesh Aggarwal (Lucknow), Yungsang Lee (Seoul)
11:00-11:30 Challenges of hepatitis B in the era of antiviral therapy Henry LY Chan
(Hong Kong)
Topic Forum (LG) (Korean)
Nov. 16 (Fri)
11:10-12:00
Topic Forum (LG) E5 (3F)
Chairperson(s) Hiun Suk Chae (Uijeongbu), Young-Eun Joo (Gwangju)
11:10-11:20 Risk factors including fecal markers for hospitalization in patients with ulcerative colitis Byung Jin Kwon
(Yangsan)
11:20-11:30 Mucosal healing is associated with transmural healing after 1-year treatment with anti-TNF agents in pediatric Crohn's disease patients Ben Kang
(Daegu)
11:30-11:40 Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on adalimumab maintenance therapy Eun Hye Oh
(Seoul)
11:40-12:00 Keynote Lecuture: Evolving monitoring for IBD patient care in clinical practice Byung Ik Jang
(Daegu)
Marshall & Warren Lectureship
Nov. 16 (Fri)
11:30-12:00
Marshall & Warren Lectureship Auditorium (3F)
Chairperson(s) Ian Roberts-Thomson (Hawthorn), Hyun Chae Jung (Seoul)
11:30-12:00 Chemoprevention of gastric cancer by H. pylori eradication and its underlying mechanism Nayoung Kim
(Seongnam)
Live Demonstration 1
Nov. 16 (Fri)
14:00-15:30
Live Demonstration 1 Auditorium (3F)
Chairperson(s) Chan Sup Shim (Seoul), Christopher Jen Lock Khor (Singapore), James Lau (Hong Kong)
14:00-15:30 LGI Hiroshi Kashida
14:00-15:30 PB Seungmin Bang
14:00-15:30 PB Se Woo Park
Symposium GI-02 (UG)
Nov. 16 (Fri)
14:00-15:30
Gastric carcinogenesis: Host, microbiome, and their interactions 101 (1F)
Chairperson(s) Kwong Ming Fock (Singapore), Ki Baik Hahm (Seongnam)
14:00-14:20 Identification of genetic susceptibility for gastric cancer through genome-wide association studies Benjamin Wong
(Hong Kong)
14:20-14:40 Non-coding RNA and gastric cancer Sang Kil Lee
(Seoul)
14:40-15:00 Interactions between human and Helicobacter pylori in gastric carcinogenesis Richard Peek
(Nashville)
15:00-15:20 Non-Helicobacter pylori microbiome in gastric carcinogenesis Yoshio Yamaoka
(Yufu)
15:20-15:30 Q&As
Symposium EN-04 (UG)
Nov. 16 (Fri)
14:00-15:30
Recent advances of EUS: one more step 102 (1F)
Chairperson(s) Laurent Palazzo (Paris), Dong-Wan Seo (Seoul)
14:00-14:20 Enhanced EUS imaging: Elastography and contrast enhanced EUS Laurent Palazzo
(Paris)
14:20-14:40 EUS-FNA/FNB in the UGI tract: when and how? Rungsun Rerknimitr
(Bangkok)
14:40-15:00 Present status of EUS in pancreatic cystic lesions Yousuke Nakai
(Tokyo)
15:00-15:20 Interpretation of EUS-FNA/FNB specimen: Pathologist’s view Keetaek Jang
(Seoul)
15:20-15:30 Q&As
Symposium LV-02
Nov. 16 (Fri)
14:00-15:30
Chronic hepatitis B: future treatment for the cure 103 (1F)
Chairperson(s) Seung Woon Paik (Seoul), Shiv Kumar Sarin (New Delhi)
14:00-14:20 Potential therapeutic target in hepatitis B virus life cycle Jia-Horng Kao
(Taipei)
14:20-14:40 Current strategies to maximize HBsAg loss in patients with CHB Pietro Lampertico
(Milan)
14:40-15:00 Immunologic modulation for hepatitis B treatment Antonio Bertoletti
(Singapore)
15:00-15:20 Emerging drugs?& new therapeutic perspectives?for HBV Henry LY Chan
(Hong Kong)
15:20-15:30 Q&As
Symposium PB-02
Nov. 16 (Fri)
14:00-15:30
Cutting edge of pancreatic diseases 104 (1F)
Chairperson(s) Chengwei Tang (Chengdu), Hsiu-Po Wang (Taipei)
14:00-14:20 Updates on the management of severe acute pancreatitis Chengwei Tang
(Chengdu)
14:20-14:40 Pancreatic enzyme replacement therapy in chronic pancreatitis Hong Sik Lee
(Seoul)
14:40-15:00 Updates on Ig G4 related diseases Kazuichi Okazaki
(Hirakata)
15:00-15:20 Current status of pancreatic cystic neoplasm management Aiming Yang
(Beijing)
15:20-15:30 Q&As
Combined-01 (Liver, PB)
Nov. 16 (Fri)
14:00-15:30
Autoimmune diseases of the liver and biliary system: the essentials 105 (1F)
Chairperson(s) Myung-Hwan Kim (Seoul), Sook-Hyang Jeong (Seongnam)
14:00-14:20 Autoimmune hepatitis - 2018 Update Atsushi Tanaka
(Tokyo)
14:20-14:40 Primary biliary cholangitis: from diagnosis to treatment Kyung-Ah Kim
(Goyang)
14:40-15:00 Primary sclerosing cholangitis: what is the best management in the 21stcentury? Hiroyuki Isayama
(Tokyo)
15:00-15:20 IgG4-related sclerosing cholangitis: when to suspect, how to diagnose, and how to treat Taejun Song
(Seoul)
15:20-15:30 Q&As
Symposium GI-03 (LG)
Nov. 16 (Fri)
14:00-15:30
Shifting paradigm in IBD management 202 (2F)
Chairperson(s) Joo Sung Kim (Seoul), Siew Chien Ng (Hong Kong)
14:00-14:20 New drugs on the horizon: Targeting cytokines, cell trafficking, and more Choon Jin Ooi
(Singapore)
14:20-14:40 Fecal microbiota transplantation for IBD: Ready to use? Siew Chien Ng
(Hong Kong)
14:40-15:00 Toward improving quality of care in IBD management David Todd Rubin
(Chicago)
15:00-15:20 Things you should know when managing elderly IBD patients Jae Hee Cheon
(Seoul)
15:20-15:30 Q&As
Symposium EN-05 (UG)
Nov. 16 (Fri)
14:00-15:30
Current status and future direction for early esophageal cancer treatment strategy 203 (2F)
Chairperson(s) Joo Young Cho (Seongnam), Tsuneo Oyama (Saku)
14:00-14:20 High magnification and NBI imaging endoscopy for early esophageal cancer Gwang Ha Kim
(Busan)
14:20-14:40 ESD with multimodal treatment for esophageal cancer Tsuneo Oyama
(Saku)
14:40-15:00 Ablation therapy for esophageal cancer: when and how? Jeong Hoon Lee
(Seoul)
15:00-15:20 Management of esophageal stricture after endoscopic treatment Yang Won Min
(Seoul)
15:20-15:30 Q&As
APDW 2018 Plenary Oral 1
Nov. 16 (Fri)
14:00-15:30
Plenary Oral 1 205A (2F)
Chairperson(s) Jidong Jia (Beijing), Dong Ki Lee (Seoul)
14:00-14:10 EUS-guided gastrojejunostomy using a lumen apposing metal stent in patients with symptomatic gastric outlet obstruction Adeel Urrehman
(Karachi)
14:10-14:20 Higher peak dose rather than prolonged duration of corticosteroid increases the risk of hepatitis flare in patients with chronic hepatitis B Becky Wing-Yan Yuen
(Shatin)
14:20-14:30 Roux en Y gastric bypass is associated with better short term cardiovascular risk reduction than sleeve gastrectomy in a multi-ethnic cohort Baldwin Po Man Yeung
(Singapore)
14:30-14:40 Incidence and risk factors for alcohol relapse after liver transplantation for alcoholic liver disease. Dong Hyun Sinn
(Seoul)
14:40-14:50 New staining method using antibody of methionyl-tRNA synthetase for brushing cytology can differentiate indeterminate bile duct strictures. Sung Ill Jang
(Seoul)
14:50-15:00 Is the new T1 category defined by the 8th edition AJCC pancreatic cancer staging system an improvement? An evaluation by multinational data Wooil Kwon
(Seoul)
15:10-15:20 PCSK9 inhibits HCC cell malignant biological behavior via binding to GSTP1 Mingyan He
(Nanchang)
E-poster Presentations-05 (UG)
Nov. 16 (Fri)
14:00-15:30
H. pylori R1A (3F)
Chairperson(s) Jung Mogg Kim (Seoul), Khien Van Vu (Hanoi)
14:00-14:06 Prevalence of helicobacter pylori in eastern province Mongolia Munkhtur Dandar
(Choibalsan)
14:06-14:12 The role of migration inhibitory factor (MIF) in H. pylori infection and gastric cancer development Chun-Sheng Shen
(Kaohsiung)
14:12-14:18 Management of antibiotics-resistant helicobacter pylori infection -Perspectives from Vietnam Khien Van Vu
(Hanoi City)
14:18-14:24 Risk of overall mortality after helicobacter pylori treatment in patients with hypertension Young-Il Kim
(Goyang)
14:24-14:30 Efficacies of genotypic resistance-guided vs empirical therapy for refractory helicobacter pylori infection- A randomized controlled trial Jyh-Ming Liou
(Taipei)
14:30-14:36 Discriminating subjects with past helicobacter pylori infection among seronegative and unimpaired gastric secretory ability. Hyungyung Kwon
(Seoul)
14:36-14:42 Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria Ping-I Hsu
(Kaohsiung)
14:42-14:48 Modified amoxicillin triple therapy vs standard triple therapy for eradication of helicobacter pylori infection: A randomized control trial Dennis Franco Fernandez
(Manila)
14:48-14:54 The microbiota regulates bone marrow-derived mesenchymal stem cells in gastrointestinal cancer Huiying Shi
(Wuhan)
14:54-15:00 Association of helicobacter pylori infection with fatty liver infiltration in dyspeptic patients Basit Siddiqui
(Karachi)
15:00-15:06 Online registry for nationwide database of current trend of helicobacter pylori eradication in Korea: correlation of the density of antibiotics usage with eradication success Beom Jin Kim
(Seoul)
15:06-15:12 14-day bismuth high dose dual therapy is a robust second-line rescue therapy of H.pylori infection Alex Hwong-Ruey Leow
(Kuala Lumpur)
E-poster Presentations-06 (LG)
Nov. 16 (Fri)
14:00-15:30
Inflammatory bowel disease (2) R1C (3F)
Chairperson(s) Young Sook Park (Seoul), Zhihua Ran (Shanghai)
14:00-14:06 Efficacy of cumulative corticosteroid dose before the treatment with biologics on the outcome of UC patients: A retrospective multicenter experience Yoshitaka Ueno
(Hirosima)
14:06-14:12 Clinical significance of granulomas in Crohn`s disease: A meta-analysis Seung Wook Hong
(Seongnam)
14:12-14:18 Dose medical acceleration improve outcomes in ulcerative colitis patients who are in clinical remission but have endoscopic inflammation? Ji Young Chang
(Seoul)
14:18-14:24 Increased risk of end-stage renal disease in metabolically healthy patients with Crohn's disease : A nationwide population-based study Seona Park
(Seoul)
14:24-14:30 Increased risk of parkinson's disease in young patients with Crohn's disease: a nationwide population-based study Seona Park
(Seoul)
14:30-14:36 Increased risk of diabetes in inflammatory bowel disease: A nationwide population-based study in Korea Eun Ae Kang
(Seoul)
14:36-14:42 Increased risk of anxiety and depressive disorders associated with inflammatory bowel disease: a nationwide population-based study Jaeyoung Chun
(Seoul)
14:42-14:48 High-sensitivity C-reactive protein/albumin ratio are associated with disease activity of inflammatory bowel disease Ailing Liu
(Beijing)
14:48-14:54 Characteristics of extra-intestinal manifestations (EIM) in a local cohort of patients with inflammatory bowel disease (IBD) Huiyu Lin
(Singapore)
14:54-15:00 Microbial signature associated with prognosis of Crohns disease Dong Il Park
(Seoul)
15:00-15:06 A comparative study of infusion reactions associated with infliximab, vedolizumab and ustekinumab: Experience from a tertiary hospital in Singapore. Andrew Xia Huang Tan
(Singapore)
15:06-15:12 Low intestinal alkaline phosphatase ratio may predict clinical recurrence in patients with Crohn disease Seon-Young Park
(Gwangju)
15:12-15:18 Development of machine learning model to predict the prognosis in patients with inflammatory bowel disease (IBD) Youni Choi
(Inchoen)
15:18-15:24 Prevalence and associated factors of anemia in Taiwanese inflammatory bowel disease patients Yew Loong Leong
(Taipei)
15:24-15:30 Post-hoc analysis from the Phase 2 FITZROY study with the selective JAK1 inhibitor filgotinib: effect of disease duration and location on clinical remission in Crohns disease patients Wai Keung Leung
(Hong Kong)
E-poster Presentations-07 (LV)
Nov. 16 (Fri)
14:00-15:30
Alcoholic and nonalcoholic liver disease R2A (3F)
Chairperson(s) Manoj Kumar Sharma (New Delhi), Sungjin Hong (Shanghai)
14:00-14:06 Protocatechuic acid-mediated Sirtuin3 activation promotes fatty acid metabolism in non-alcoholic fatty liver disease Jihong Yao
(Dalian)
14:06-14:12 Effectiveness of probiotics in improving minimal hepatic encephalopathy in patients with compensated liver cirrhosis a meta-analysis Higinio Mappala
(Manila)
14:12-14:18 Antioxidants in patients with alcoholic liver disease Le Thi Thu Hien
(Thai Nguyen)
14:18-14:24 Relationship between cytokines and alcoholic liver disease Le Thi Thu Hien
(Thai Nguyen)
14:24-14:30 Severity of non-alcoholic fatty liver disease in Hong Kong and Australia Nicole Phoebe Tanner
(North Point)
14:30-14:36 Alcoholic fatty liver disease among unsafe drinkers: A prospective, community cohort, 7-year follow-up study Madunil Anuk Niriella
(Ragama)
14:36-14:42 Lifestyle Intervention enabled by mobile technologies leading to weight loss in patients with non-alcoholic fatty liver disease: a randomized controlled trial Su Lin Lim
(Singapore)
14:42-14:48 5% weight loss induces NAFLD fibrosis as defined through interval elastography - Preliminary data from a single tertiary hospital in Singapore Wei De Tee
(Singapore)
E-poster Presentations-08 (Surgery)
Nov. 16 (Fri)
14:00-15:30
Surgery: Upper GI, lower GI, others R2C (3F)
Chairperson(s) Kyo Young Song (Seoul), Kent-Man Chu (Hong Kong)
14:00-14:06 Body mass index and mortality in patients with gastric cancer: A large cohort study Jung Hwan Lee
(Incheon)
14:06-14:12 Tranalation and valiadation of eortc qlq-cr29 quality of life questionnaire (sinhala version) Dakshitha Wickramasinghe
(Colombo)
14:12-14:18 Enhanced recovery after colorectal surgery (ERAS) protocol in Sri Lanka an assessment of current practice of colorectal surgery among general surgical units in a developing country in south Asia Chamila Lakmal
(Colombo)
14:18-14:24 Non-exposure simple suturing endoscopic full-thickness resection (NESS-EFTR) with sentinel basin dissection in patients with early gastric cancer Bang Wool Eom
(Goyang)
14:24-14:30 Survival outcomes of local excision versus radical resection for early colorectal cancer in young patients: A propensity matching study Bin Cao
(Beijing)
14:30-14:36 Treatment strategy of intraperitoneal and systemic chemotherapy combined with gastrectomy for gastric cancer with peritoneal metastasis Daisuke Kobayashi
(Nagoya)
14:36-14:42 A single institution experience of laparoscopic gastrectomy in advanced gastric cancer: analysis of postoperative morbidities and long-term oncologic outcomes Sa-Hong Min
(Seongnam)
14:42-14:48 Risk factor and treatments of chylothorax after esophageal cancer surgery Moyuru Yamada
(Toyonakacity)
14:48-14:54 A single center experience of 50 fundoplications in Hong Kong Ho Kiu Grace Wong
(Hong Kong)
Symposium GI-04 (GI Cancer)
Nov. 16 (Fri)
14:00-15:30
Gastirc cancer, are we in new era for management? E1+2 (3F)
Chairperson(s) Hyunyong Jeong (Daejeon), James R. Goldenring (Nashville)
14:00-14:20 The global change in epidemiology of gastric cancer Jin Young Park
(Lyon)
14:20-14:40 Role of?SPEM in gastric carcinogenesis James R. Goldenring
(Nashville)
14:40-15:00 Do we have proper surgical modalities to preserve functional aspect after gastric cancer surgery? Keun Won Ryu
(Goyang)
15:00-15:20 Current treatment landscape and future perspectives in patients with advanced gastric cancer Sung Eun Kim
(Busan)
15:20-15:30 Q&As
Free Paper (PB 3) (Korean)
Nov. 16 (Fri)
14:00-15:30
KDDW Free Paper (PB 03) E3 (3F)
Chairperson(s) Jaeseon Kim (Seoul), Seon Mee Park (Cheongju)
14:00-14:10 Acalculous cholecystitis in burn intensive care unit patients: Incidence and predisposing factors Hoongoo Lee
(Hwaseong)
14:10-14:20 Clinical characteristics of colonic adenoma according to characteristics of gallstones Jaehyun Tae
(Seoul)
14:20-14:30 Chronological changes of epidemiologic characteristics of gallstone over last 20years in Korean single large volume center Jiyong Zhao
(Seoul)
14:30-14:40 Incidence and risk factors for gallstone formation after surgical and endoscopic therapy Soyeong Kim
(Daegu)
Chairperson(s) Jin Lee (Hwasung), Jong Hyeok Kim (Anyang)
14:40-14:50 Incidence of cholelithiasis in patients with inflammatory bowel disease Sooyeong Kwak
(Daegu)
14:50-15:00 Biliary tuberculosis impersonating as cholangiocarcinoma: Single- center experiences Jae Hyuck Jun
(Daejeon)
15:00-15:10 Outcomes of endoscopic papillary large balloon dilation for bile duct stones: Before and after international consensus guideline Dae Jung Kim
(Suwon)
KDDW Free Paper (LG 3) (Korean)
Nov. 16 (Fri)
14:00-15:30
KDDW Free Paper (LG 3) E5 (3F)
Chairperson(s) Kooklae Lee (Seoul), Soon Man Yoon (Cheongju)
14:00-14:10 Cost drivers for inflammatory bowel disease care: a population-based study using the korean national health insurance claims data (2006-2015) Jung-Wook Kim
(Seoul)
14:10-14:20 Real life effectiveness and safety of vedolizumab as induction therapy for Korean IBD patients in whom anti-TNF treatment failed: A prospective cohort study Jeongseok Kim
(Seoul)
14:20-14:30 Influence of Vitamin D status on the clinical course of ulcerative colitis Nam Seok Ham
(Seoul)
Chairperson(s) Moon Sung Lee (Bucheon), Bo-In Lee (Seoul)
14:30-14:40 Impact of family history of colorectal cancer on age-specific prevalence of colorectal Seulki Kim
(Seoul)
14:40-14:50 The association of cigarette smoking and alcohol consumption with sessile serrated adenoma in 30-49 year-old subjects Ji Young Lee
(Seoul)
14:50-15:00 prevalence of and risk factors for colorectal neoplasia in asymptomatic young adults aged 20 to 39 years Jin Ju Song
(Seoul)
15:00-15:10 Does colon diverticulosis raise the risk of adenomatous colon polyp in patients with colorectal cancer? Suyun Oh
(Suwon)
WEO Honorary Lecture
Nov. 16 (Fri)
16:00-17:00
WEO Honorary Lectureship 104 (1F)
Chairperson(s) Jean-Francois Rey (Saint Laurent Du Var)
16:00-16:50 Paving the way to the globalization of advanced endoscopy Hisao Tajiri
(Tokyo)
16:50-17:00 Q&A
Live Demonstration 2
Nov. 16 (Fri)
16:00-17:30
Live Demonstration 2 Auditorium (3F)
Chairperson(s) Dong Ki Lee (Seoul), Shutian Zhang (Beijing), Mahesh Kumar Goenka (Kolkata)
16:00-17:30 UGI, PB Enqiang Linghu
16:00-17:30 UGI Jun Chul Park
Symposium GI-05 (LG)
Nov. 16 (Fri)
16:00-17:30
The cutting edge issues in management of IBD 2018 102 (1F)
Chairperson(s) Suk-Kyun Yang (Seoul), Jiaming Qian (Beijing)
16:00-16:20 What should be the therapeutic targets in IBD therapy? Siew Chien Ng
(Hong Kong)
16:20-16:40 Proper positioning of various drugs in therapeutic algorithm David Todd Rubin
(Chicago)
16:40-17:00 Place of TDM in optimal use of biologics Akira Andoh
(Otsu)
17:00-17:20 Managing Crohn's disease after surgery Kang-Moon Lee
(Suwon)
17:20-17:30 Q&As
Symposium LV-03
Nov. 16 (Fri)
16:00-17:30
Chronic hepatitis C in DAA era 103 (1F)
Chairperson(s) Kwan Soo Byun (Seoul), Rakesh Aggarwal (Lucknow)
16:00-16:20 HCV screening in general population: is this cost-effective in DAA era? Rakesh Aggarwal
(Lucknow)
16:20-16:40 Is there difficult to treat population in HCV patients in DAA era? Naoya Sakamoto
(Sapporo)
16:40-17:00 Increased risk of HCC following DAA: fact or fiction?/Follow up strategy after SVR in chronic hepatitis C Yasuhiro Asahina
(Tokyo)
17:00-17:20 DAA first versus transplantation first in decompensated cirrhotic HCV patients Young-Suk Lim
(Seoul)
17:20-17:30 Q&As
Combined-02 (Endoscopy-Surgery)
Nov. 16 (Fri)
16:00-17:30
Gastrointestinal diseases and treatments in obese patients (KSGE combined session) 105 (1F)
Chairperson(s) Sung Kwan Shin (Seoul), Joo Ho Lee (Seoul)
16:00-16:20 Functional gastrointestinal disorders in obese patients Yong Sung Kim
(Iksan)
16:20-16:40 Gastrointestinal tumors associated with obesity Jin-Hyeok Hwang
(Seongnam)
16:40-17:00 Endoscopic treatments for morbid obesity Hyuk Soon Choi
(Seoul)
17:00-17:20 Surgical treatments for morbid obesity Takeshi Naitoh
(Sendai)
17:20-17:30 Q&As
Symposium GI-06 (UG)
Nov. 16 (Fri)
16:00-17:30
All about GIST on UGI tract 202 (2F)
Chairperson(s) Chang-Hun Yang (Gyeongju), Byung-Wook Kim (Incheon)
16:00-16:20 Pathologic diagnosis; focused on prognostic factor Gu Hyun Kang
(Seoul)
16:20-16:40 Endoscopic treatment: when and how? Hanglak Lee
(Seoul)
16:40-17:00 Surgical treatment: when and how? Hyundong Chae
(Daegu)
17:00-17:20 Target therapy: when and how? Dong-Hoe Koo
(Seoul)
17:20-17:30 Q&As
Symposium PB-03
Nov. 16 (Fri)
16:00-17:30
Recent advances in intra- and extrahepatic cholangiocarcinoma: promising or practice changing? 203 (2F)
Chairperson(s) Ho Soon Choi (Seoul), Ji Kon Ryu (Seoul), Dong Sup Yoon (Seoul)
17:20-17:30 Dong Hee Koh
(Hwaseong)
16:00-16:20 Pathogenesis and molecular characterization: from genetics to signaling pathways Young Nyun Park
(Seoul)
16:20-16:40 Pathologic classification: new concepts Kyoungbun Lee
(Seoul)
16:40-17:00 Endoscopic management: from ERCP to EUS Masayuki Kitano
(Wakayama)
17:00-17:20 Selection of patients for curative resection and role of surgery: from resection to transplantation Masayuki Ohtsuka
(Chiba)
APDW 2018 Plenary Oral 2
Nov. 16 (Fri)
16:00-17:30
Plenary Oral 2 205A (2F)
Chairperson(s) Kent-Man Chu (Hong Kong), Ming-Shiang Wu (Taipei)
16:00-16:10 The relationship between enterobacterial flora and prognosis in patient with ulcerative colitis Tomoya Sugiyama
(Nagakute)
16:10-16:20 Analysis of key genes and signaling pathways involved in helicobacter pylori-associated gastric cancer based on the cancer genome atlas database and RNA-sequencing Yi Hu
(Nanchang)
16:20-16:30 Features of post-colonoscopy colorectal cancer and survival times of patients in Korea Jae Myung Cha
(Seoul)
16:30-16:40 An open-label, multicenter, randomized controlled trial of vonoprazan versus esomeprazole as part of first-line triple therapy for helicobacter pylori infection Hiroyuki Tamaki
(Takamatsu)
16:40-16:50 Evolving the novel per oral endoscopic myotomy and fundoplication (POEM+F) procedure: Application of endoscopic hand-suturing technique Akiko Ueno
(Tokyo)
16:50-17:00 POEM is more effective than balloon dilation in all achalasia subtypes: based on data from a single tertiary referral center Ga Hee Kim
(Seoul)
17:00-17:10 Simple liquid arrays of three aptamers are valuable for the diagnosis of gastric cancer Yuting He
(Nanchang)
17:10-17:20 Deep learning versus simple clinical scores for prediction of advanced neoplasia in colorectal cancer screening Hyo-Joon Yang
(Seoul)
17:20-17:30 gut microbiota from patients with colorectal cancer promotes the progression of intestinal adenoma in apcmin/+ mice Hai-Long Cao
(Tianjin)
E-poster Presentations-09 (UG, Motility)
Nov. 16 (Fri)
16:00-17:30
H. pylori, other upper GI disorders R1A (3F)
Chairperson(s) Jae Myung Park (Seoul), Amit Kumar Dutta (Vellore)
16:00-16:06 The study of motor and evacuation functions of the stomach and rectum in patients with functional dyspepsia and irritable bowel syndrome Oybek Otabekovich Usmonov
(Tashkent)
16:06-16:12 Objective and subjective approaches in the treatment of patients with GERD with a syndrome of vegetative dystonia Oybek Otabek O'g'li Usmonov
(Tashkent)
16:12-16:18 Duodenal eosinophil and mast cell count and its relation with functional dyspepsia; A case control study Madhusudan Saha
(Sylhet)
16:18-16:24 Efficacy of endoscopic therapeutic procedures in non variceal upper gastrointestinal bleeding in hanoi medical university hospital from 2013 to 2017 Hang Dao
(Hanoi)
16:24-16:30 The association between electronic cigarette smoking and dyspepsia in adult urban population Ahmad Fariz Malvi Zamzam Zein
(Cirebon)
16:30-15:36 Current risk factors for peptic ulcer disease in the background of declining frequency of helicobacter pylori infection in patients with dyspepsia Amit Kumar Dutta
(Vellore)
16:36-16:42 Impact of upper gastrointestinal symptoms on quality of life in type 2 diabetes patients: preliminary study in Banten province hospital, Indonesia Laras Budiyani
(Serang)
16:42-16:48 Systematic review and meta-analysis: prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome Ayesha Shah
(Brisbane)
16:48-16:54 The association between peptic ulcer disease and osteoporosis: A 12-year follow up of the Korean genome and epidemiology study Kanglok Lee
(Incheon)
16:54-17:00 H. pylori genotyping and genomic diversity assessment ingastric biopsies from residents of high altitude ( ladakh ) and lower plains of north India Nisha Sharma
(Delhi)
17:00-17:06 Cost-effectiveness of a tailored helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients Seri Ryu
(Seoul)
E-poster Presentations-10 (LG)
Nov. 16 (Fri)
16:00-17:30
Inflammatory bowel disease (3) R1C (3F)
Chairperson(s) Jae Hee Cheon (Seoul), Vineet Ahuja (New Delhi)
16:00-16:06 The COX-2/PGE2 pathway is central for efficacy of TNF inhibitors and intestinal epithelial regeneration in ulcerative colitis Ole Haagen Nielsen
(Herlev)
16:06-16:12 Using anaemia as an isolated marker to predict the extent of inflammatory bowel disease at diagnosis Hang Hoi Michael Wong
(Hong Kong)
16:12-16:18 Predictors of using traditional medicine, complementary and alternative medicine in inflammatory bowel disease in Hong Kong: the first patients self report in ethnic Chinese Jessica Y L Ching
(Hong Kong)
16:18-16:24 Age at onset, maintenance therapy and erythrocyte sedimentation rate are independent risk factors for anal fistula in Crohns disease Guanghui Lian
(Changsha)
16:24-16:30 Disease activity and severity of ulcerative colitis are associated with increased mucosal candida colonization and Beta-D-Glucan levels Jimil Hiteshbhai Shah
(Chandigarh)
16:30-15:36 Incidence and outcomes of acute severe ulcerative colitis (ASUC) - A retrospective cohort study in a Singapore tertiary institution Kaina Chen
(Singapore)
16:36-16:42 Molecular detection of pathogenic gut bacteria in inflammatory bowel disease (IBD) patients is not influenced by disease activity Deborah Chia Hsin Chew
(Malaysia)
16:42-16:48 Trends in inflammatory bowel disease incidence in Korea: A nationwide population-based study 2004-2015 Jae Jun Park
(Seoul)
16:48-16:54 Study of predictive factors and clinical implication of deep mucosal healing in ulcerative colitis Deepak Gupta
(Mumbai)
16:54-17:00 Natural history of inflammatory bowel disease from 1970 to 2017 - Results from a large single center in Singapore Miao Shan Lim
(Singapore)
E-poster Presentations-11 (LV)
Nov. 16 (Fri)
16:00-17:30
Autoimmune liver disease, cirrhosis R2A (3F)
Chairperson(s) Il Han Song (Cheonan), Kang Mo Kim (Seoul)
16:00-16:06 Fluorofenidone reveals a novel function for glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and hepatic fibrosis Yu Peng
(Changsha)
16:06-16:12 Rapid endoscopic ultrasound screening of hepatopulmonary syndrome (RUSH): a safe, simple and quick procedure for gastroenterologist Rahul Pundlik Talele
(Meerut)
16:12-16:18 Outcomes of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis. Rabeea Azmat
(Karachi)
16:18-16:24 PXR activation by ginkgolide a restores inflammation and tight junction integrity in cirrhosis Balasubramaniyan Vairappan
(Pondicherry)
16:24-16:30 Tofacitinib ameliorates inflammation effectively in immune-mediated hepatic injury Han Wang
(Wuhan)
16:30-15:36 The demographic, clinical features, response to treatment and outcome of autoimmune hepatitis (AIH) patients in multi-ethnic Malaysia since 2002 Yun Chien Chung
(Batu Caves)
16:36-16:42 The distribution of non-tumoral portal vein thrombosis in liver cirrhosis and its relationship with wall shear stress Zongfang Li
(Xi'an)
16:42-16:48 A gravity-assisted liver stiffness measurement Itsuo Nagayama
(Minami Uonuma)
16:48-16:54 Repeated versus single treatment of esophageal variceal ligation after esophageal variceal bleeding: Multicenter retrospective study Young Hwan Choi
(Seoul)
16:54-17:00 Gastric vascular ectasia (GAVE) not rare cause of GI bleed in liver cirrhosis ; cross sectional study on factors associated with GAVE with or with out portal hypertensive gastropathy (PHG) in liver cirrhosis in tertiary care hospital Karachi Paksitan Om Parkash
(Karachi)
E-poster Presentations-12 (PB)
Nov. 16 (Fri)
16:00-17:30
Endoscopic retrograde cholangiopancreatography (ERCP) R2C (3F)
Chairperson(s) Sang-Woo Cha (Seoul), Ari Fahrial Syam (Depok)
16:00-16:06 Demonstrating competence in endoscopic retrograde cholangiopancreaticography (ERCP): recently credentialed operators performance for deep biliary cannulation over 1 year period from tertiary care hospital in Pakistan. Om Parkash
(Karachi)
16:06-16:12 A retrospective comparison of transpancreatic septotomy and needle knife sphincterotomy in difficult biliary cannulation Cherng Harng Lim
(Chanhua)
16:12-16:18 The usefulness of newly modified non-flared fully covered metal stent of 12 mm-diameter comparing with conventional stent for periampullary malignant biliary strictures Jin Yong Lee
(Bucheon)
16:18-16:24 Bile duct injury after laparoscopic cholecystectomy: new classification and novel approach for the management in emergency situations. Chintan Patel
(Surat)
16:24-16:30 Patterns of bile duct injuries observed during endoscopic retrograde cholangiogram: 13 years of experience in a tertiary care referral centre in south Asia Chamila Lakmal
(Colombo)
16:30-15:36 Endoscopic management of difficult biliary stones; utility of ERCP using short type double balloon endoscope in patients with surgically altered anatomy Masaaki Shimatani
(Osaka)
16:36-16:42 The sphincter-preserving effect of duodenal papilla occlusion by SureClip from MicroTech Yonghui Huang
(Beijing)
16:42-16:48 Clinical utility of endoscopic therapy for bile leak associated with posthepatobiliary surgery Hideyuki Shiomi
(Kobe)
16:48-16:54 A novel technique using loop-device for the repositioning of ENBD catheter in ERCP Jae Min Lee
(Seoul)
16:54-17:00 Efficacy of endoscopic plastic stents for anastomotic biliary strictures after right lobe adult living donor liver transplantation Min Su You
(Seoul)
17:00-17:06 Proper initial stent type for palliative bilateral biliary drainage for unresectable advanced malignant hilar obstruction Young Hoon Choi
(Seoul)
17:06-17:12 Risk of failure and complications of endoscopic retrograde cholangiopancreatography; comparison of elderly and young pakistani patients Talal Khurshid
(Islamabad)
PG Course-LG (Korean)
Nov. 16 (Fri)
16:00-17:30
Current status and future perspectives in management of small bowel diseases E1+2 (3F)
Chairperson(s) Hyun Soo Kim (Gwangju), Sung-Ae Jung (Seoul)
16:00-16:20 Optimal approach to small bowel bleeding Hyun Jung Lee
(Seoul)
16:20-16:40 Radiologic diagnosis of small bowel diseases Jeong Kyong Lee
(Seoul)
16:40-17:00 Therapeutic role of enteroscopy Sung Noh Hong
(Seoul)
17:00-17:20 Interesting cases of various small bowel diseases Bong Min Ko
(Bucheon)
17:20-17:30 Q&As
Free Paper (PB 4) (Korean)
Nov. 16 (Fri)
16:00-17:30
KDDW Free Paper (PB 04) E3 (3F)
Chairperson(s) Seong Woo Nam (Seoul), Young Koog Cheon (Seoul)
16:00-16:10 Antitumor effects of flavokawain B on cholangiocarcinoma Young Hoon Choi
(Seoul)
16:10-16:20 Carbohydrate antigen 19-9 as a prognostic marker of intrahepatic cholangiocarcinoma after surgical resection Gunn Huh
(Seoul)
16:20-16:30 Clinical relevance of BilIN in surgical margin of perihilar cholangiocarcinoma Soong Goo Jung
(Seoul)
Chairperson(s) Young Soo Moon (Busan), Se-Joon Lee (Yongin)
16:30-16:40 Efficacy and safety of simultaneous side-by-side bilateral placement of braided-type metal stents using 6F-introducer for unresectable malignant hilar bile duct obstruction: A retrospective feasibility study Doo Hyun Ko
(Inchon)
16:40-16:50 Comparison of preoperative CT scan, EUS Findings, and Histopathologic Findings of Gallbladder Polyps Larger than 1 cm in Size Jae Kook Yang
(Cheonan)
16:50-17:00 Long-term outcomes of endoscopic papillectomy after an insulated plastic pancreatic stent placement Sun Ung Youn
(Suwon)
AGA-APAGE
Nov. 16 (Fri)
16:00-18:00
From bench to clinic in gastric cancer: Where are we headed? 101 (1F)
Chairperson(s) Emad Munir El-Omar (Sydney), Sang Woo Lee (Ansan)
16:00-16:25 The molecular pathogenesis of gastric cancer ? state of the art Timothy Cragin Wang
(New York)
16:25-16:50 The role of the gastric microbiome in H. pylori-induced gastric cancer Richard Peek
(Nashville)
16:50-17:15 Prevention of gastric cancer ? opportunities and potential problems Kentaro Sugano
(Shimotsuke)
17:15-17:40 National gastric cancer screening- outcomes and future challenges Il Ju Choi
(Goyang)
17:40-18:00 Q&As

Go to Top

Supported by
Member Societies
  • President : Dong Ki Lee
  • Business License No. 106-82-07189

Copyright© 2008 The Korean Society of Gastroenterlogy. All Rights Reserved.

Room 305, 31 Seolleung-ro 86 gil, Gangnam-gu, Seoul, 06193, Korea
Associated Societies
Secretariat